World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 53 4056 3726 232 216 268 12845

Jade Ghosn publications per year

The chart shows the history of publications by Jade Ghosn between 2002 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jade Ghosn published across 24 years, from 2002 to 2025, averaging 14.3 papers a year. Output peaked at 45 publications in 2021. 42 of the 344 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 2002 to 2025. Vertical axis: number of publications, 0 to 45. Peak 45 publications in 2021. 2002: 3 publications 2003: 3 publications 2004: 6 publications 2005: 7 publications 2006: 12 publications 2007: 6 publications 2008: 20 publications 2009: 8 publications 2010: 16 publications 2011: 8 publications 2012: 12 publications 2013: 11 publications 2014: 8 publications 2015: 16 publications 2016: 7 publications 2017: 14 publications 2018: 7 publications 2019: 13 publications 2020: 14 publications 2021: 45 publications 2022: 40 publications 2023: 26 publications 2024: 19 publications 2025: 23 publications
2002 2025

344 publications in total across all disciplines

View publications per year as a table
Jade Ghosn: publications per year, 2002 to 2025
Year Publications
2002 3
2003 3
2004 6
2005 7
2006 12
2007 6
2008 20
2009 8
2010 16
2011 8
2012 12
2013 11
2014 8
2015 16
2016 7
2017 14
2018 7
2019 13
2020 14
2021 45
2022 40
2023 26
2024 19
2025 23
Total 344
Download as CSV

Jade Ghosn publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jade Ghosn sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 265–274 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 268 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139 268
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Jade Ghosn D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jade Ghosn sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 53 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 53 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127 53
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Jade Ghosn is affiliated with Hôpital Bichat - Claude-Bernard (Hôpitaux Universitaires Paris Nord Val de Seine) in France. Their research centers primarily on medicine, with a substantial focus on infectious diseases. Across their career, they have contributed significantly to subfields such as infectious diseases, virology, epidemiology, molecular biology, and neurology.

The scientist has authored numerous studies, with notable recent papers including:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19, 2020, Science
  • Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review, 2021, Clinical Microbiology and Infection
  • Mpox in people with advanced HIV infection: a global case series, 2023, The Lancet
  • A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations, 2020, Science Translational Medicine
  • Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort, 2021, Proceedings of the National Academy of Sciences

Ghosn's collaborative work includes frequent co-authorship with:

  • Diane Descamps (37 joint publications)
  • Yazdan Yazdanpanah (34 joint publications)
  • Quentin Le Hingrat (27 joint publications)
  • Valentine Marie Ferré (26 joint publications)
  • Gilles Peytavin (23 joint publications)

The scientist has published extensively in several journals, with recurring contributions to:

  • Journal of Antimicrobial Chemotherapy (14 publications)
  • Clinical Infectious Diseases (13 publications)
  • Médecine et Maladies Infectieuses Formation (11 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (8 publications)
  • Journal of Medical Virology (7 publications)

The main research topics of Jade Ghosn's work cover:

  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Poxvirus research and outbreaks
  • Herpesvirus Infections and Treatments

This profile reflects a focus on topics that merge clinical virology and infectious disease interventions, including emerging viral threats like SARS-CoV-2 and mpox in immunocompromised populations. The scientist's contributions span clinical research, vaccine efficacy, viral serology, and epidemiological modeling related to major infectious diseases.

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

    Marc-Antoine Valantin;Camille Aubron-Olivier;Jade Ghosn;Elisabeth Laglenne

  • All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

    Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit

  • Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.

    Claudine Duvivier;Sami Kolta;Lambert Assoumou;Lambert Assoumou;Jade Ghosn

  • HIV

    Unknown

  • Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy

    Hassane Izzedine;Jean-Sebastien Hulot;Eric Villard;Catherine Goyenvalle

  • A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

    Ludivine Grzelak;Ludivine Grzelak;Sarah Temmam;Cyril Planchais;Caroline Demeret

  • Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.

    Nadège Néant;Guillaume Lingas;Quentin Le Hingrat;Jade Ghosn

  • Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection

    Abderaouf Damouche;Thierry Lazure;Véronique Avettand-Fènoël;Nicolas Huot

  • Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.

    Héloïse Flament;Héloïse Flament;Matthieu Rouland;Lucie Beaudoin;Amine Toubal

  • Omicron SARS-CoV-2 variant: What we know and what we don’t

    Unknown

  • Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

    Véronique Avettand-Fènoël;Véronique Avettand-Fènoël;Laurent Hocqueloux;Jade Ghosn;Antoine Cheret

  • Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.

    Jean-François Delfraissy;Philippe Flandre;Constance Delaugerre;Jade Ghosn

  • Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.

    Unknown

  • Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA

    Moussa Laanani;Jade Ghosn;Asma Essat;Adeline Melard

  • Acute hepatitis C in HIV‐infected men who have sex with men

    J Ghosn;S Pierre‐François;Thibault;C Duvivier

  • HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.

    Jade Ghosn;Isabelle Pellegrin;Cécile Goujard;Christiane Deveau

  • Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

    Stéphanie Dominguez;Jade Ghosn;Marc-Antoine Valantin;Aurélie Schruniger

  • Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

    Jade Ghosn;Marie-Laure Chaix;Gilles Peytavin;Elisabeth Rey

  • Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?

    Amanda Mocroft;Peter Reiss;Ole Kirk

  • Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion

    Sara Lodi;Laurence Meyer;Anthony D. Kelleher;Magdalena Rosinska

  • Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.

    Jade Ghosn;Lionel Piroth;Olivier Epaulard;Paul Le Turnier

  • Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.

    Jade Ghosn;Jean-Paul Viard;Christine Katlama;Marta de Almeida

Frequent Co-Authors

Marie-Laure Chaix
Marie-Laure Chaix Université Paris Cité
Christine Rouzioux
Christine Rouzioux Necker-Enfants Malades Hospital
Christine Katlama
Christine Katlama Sorbonne University
Jean-François Delfraissy
Jean-François Delfraissy National Ethical Consultative Committee for Life Sciences and Health
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Jean-Paul Viard
Jean-Paul Viard Assistance Publique – Hôpitaux de Paris
Laurence Meyer
Laurence Meyer University of Paris-Saclay
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various interdisciplinary career paths, especially in the healthcare and information management sectors. For those interested in clinical applications, becoming a functional medicine nurse practitioner salary offers a promising avenue. This path blends microbiological knowledge with patient-centered treatment approaches.

Alternatively, with the increasing digitization of healthcare data, careers such as a certified professional coder (CPC) have become essential. Expertise in medical coding enhances the accuracy of health records and facilitates better healthcare delivery.

For those aiming higher, a master in health information management salary can provide leadership opportunities overseeing health data systems and improving organizational efficiencies.

To ensure quality and recognition, students should consider programs like an accredited online health information management degree CAHIIM. These programs offer flexible learning options while maintaining industry standards, aligning well with microbiology graduates seeking to expand their expertise.

Best Scientists Citing Jade Ghosn

Trending Scientists

Recently Published Articles